Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Neoplasms
×
efaproxiral
×
Clear all
Filters
3
NCT00083304
2013-05-10
ENRICH
Spectrum Pharmaceuticals, Inc
Phase 3
Completed
368 enrolled